Genzyme's Mozobil gets nod for Europe approval
CAMBRIDGE – Biotechnology company Genzyme Corp. said yesterday that a panel recommended European approval for the stem cell transplant drug Mozobil. The drug is used for stem cell transplants in patients with the blood cancers non-Hodgkin’s lymphoma …
[Read the full article here]Related News:
Genzyme Gets Positive Opinion For Stem Cell Mobilization Drug Mozobil …
Researchers At UT Southwestern Find Way To Help Donor Adult Blood Stem Cells Overcome Transplant Rejection
Researchers find way to help donor adult blood stem cells overcome transplant rejection